ECSP088088A - Maleato de 3-[2-(dimetilamino)metil-(ciclohex-1-il)]fenol y sus formas cristalinas - Google Patents

Maleato de 3-[2-(dimetilamino)metil-(ciclohex-1-il)]fenol y sus formas cristalinas

Info

Publication number
ECSP088088A
ECSP088088A EC2008008088A ECSP088088A ECSP088088A EC SP088088 A ECSP088088 A EC SP088088A EC 2008008088 A EC2008008088 A EC 2008008088A EC SP088088 A ECSP088088 A EC SP088088A EC SP088088 A ECSP088088 A EC SP088088A
Authority
EC
Ecuador
Prior art keywords
phenol
methyl
crystalline forms
ciclohex
dimethylamine
Prior art date
Application number
EC2008008088A
Other languages
English (en)
Spanish (es)
Inventor
Wolfgang Hell
Martin Szelagiewicz
Michael Gruss
Jorg Berghausen
Paul Susan Margaret De
Raumer Markus Von
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of ECSP088088A publication Critical patent/ECSP088088A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EC2008008088A 2005-07-22 2008-01-08 Maleato de 3-[2-(dimetilamino)metil-(ciclohex-1-il)]fenol y sus formas cristalinas ECSP088088A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005034974A DE102005034974A1 (de) 2005-07-22 2005-07-22 Salz von Dimethylaminomethyl-phenyl-cyclohexan und dessen kristalline Formen

Publications (1)

Publication Number Publication Date
ECSP088088A true ECSP088088A (es) 2008-02-20

Family

ID=37084866

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008088A ECSP088088A (es) 2005-07-22 2008-01-08 Maleato de 3-[2-(dimetilamino)metil-(ciclohex-1-il)]fenol y sus formas cristalinas

Country Status (25)

Country Link
EP (1) EP1881956B1 (enExample)
JP (1) JP5205259B2 (enExample)
KR (1) KR20080033436A (enExample)
CN (1) CN101228110A (enExample)
AR (1) AR057674A1 (enExample)
AT (1) ATE431332T1 (enExample)
AU (1) AU2006271856B2 (enExample)
BR (1) BRPI0614057A2 (enExample)
CA (1) CA2615926A1 (enExample)
CY (1) CY1109208T1 (enExample)
DE (2) DE102005034974A1 (enExample)
DK (1) DK1881956T3 (enExample)
EC (1) ECSP088088A (enExample)
ES (1) ES2326493T3 (enExample)
HR (1) HRP20090412T1 (enExample)
IL (1) IL188897A (enExample)
MX (1) MX2008000743A (enExample)
NO (1) NO20080826L (enExample)
PE (1) PE20070368A1 (enExample)
PL (1) PL1881956T3 (enExample)
PT (1) PT1881956E (enExample)
RU (1) RU2434845C2 (enExample)
SI (1) SI1881956T1 (enExample)
WO (1) WO2007009792A1 (enExample)
ZA (1) ZA200801703B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI384986B (zh) * 2007-01-17 2013-02-11 Lg Life Sciences Ltd 抗病毒劑之順丁烯二酸單鹽以及含有該單鹽之醫藥組成物
PL2240431T3 (pl) * 2007-12-07 2017-07-31 Grünenthal GmbH Krystaliczne modyfikacje (1R,2R)-3-(3-dimetyloamino-1-etylo-2-metyIopropylo)fenoIu
EP2085081A1 (de) 2008-02-04 2009-08-05 Grünenthal GmbH 3-(2-Dimethylaminomethyl-cyclohexyl)-phenol gegen polyneuropathischen Schmerz

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE10218862A1 (de) * 2002-04-26 2003-11-06 Gruenenthal Gmbh Verfahren zur Chlorierung tertiärer Alkohole
DE10356362A1 (de) * 2003-11-28 2005-06-23 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen

Also Published As

Publication number Publication date
IL188897A0 (en) 2008-04-13
JP2009502757A (ja) 2009-01-29
ATE431332T1 (de) 2009-05-15
KR20080033436A (ko) 2008-04-16
PL1881956T3 (pl) 2009-10-30
AU2006271856A1 (en) 2007-01-25
EP1881956B1 (de) 2009-05-13
DE502006003728D1 (de) 2009-06-25
HRP20090412T1 (hr) 2009-09-30
RU2008106455A (ru) 2009-08-27
NO20080826L (no) 2008-02-20
PT1881956E (pt) 2009-06-26
CN101228110A (zh) 2008-07-23
DK1881956T3 (da) 2009-09-07
DE102005034974A1 (de) 2007-04-19
CY1109208T1 (el) 2014-07-02
WO2007009792A1 (de) 2007-01-25
BRPI0614057A2 (pt) 2012-12-11
ZA200801703B (en) 2009-08-26
AR057674A1 (es) 2007-12-12
HK1112612A1 (zh) 2008-09-12
MX2008000743A (es) 2008-03-10
IL188897A (en) 2012-12-31
RU2434845C2 (ru) 2011-11-27
SI1881956T1 (sl) 2009-10-31
ES2326493T3 (es) 2009-10-13
JP5205259B2 (ja) 2013-06-05
PE20070368A1 (es) 2007-05-12
CA2615926A1 (en) 2007-01-25
AU2006271856B2 (en) 2012-03-01
EP1881956A1 (de) 2008-01-30

Similar Documents

Publication Publication Date Title
AR116052A2 (es) Forma cristalina de clorhidrato de (-)-(1r,2r)-3-(3-dimetilamino-1-etil-2-metilpropil)-fenol
AR068369A1 (es) Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina"
CR11119A (es) Derivados de indazol oxadiazol sustituidos para uso como agonistas esfingozina 1-fosfato (sip)
MX343314B (es) Composiciones liquidas ionicas multifuncionales para superar el polimorfismo y proporcionar propiedades mejoradas a los ingredientes farmaceuticos, biologicos, nutricionales y energeticos activos.
EA200970532A1 (ru) Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола
PE20190914A1 (es) Combinacion farmaceutica de 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y un antiepileptico
PE20121080A1 (es) Composiciones concentradas de herbicidas que contienen sales de glifosato y dicamba
DOP2012000150A (es) Triazolopiridinas
AR075677A1 (es) Composicion herbicida de auxinas
NI200700068A (es) Clorhidrato de 4-[[4-[[4-(2-cianoetenil)-2,6- dimetilfenil]amino]-2- pirimidinil]amino] benzonitrilo
BR112012016059A2 (pt) "compostos intermediários e processos para a preparação de tapentadol e compostos relacionados".
CO6220902A2 (es) Formulacion en polvo del valganciclovir
BRPI1015338C1 (pt) formulação farmacêutica líquida, uso de um sal, composto e recipiente equipado com um agregado de gotejamento
TW200640445A (en) N-halogenated amino acids, N, N-dihalogenated amino acids and derivatives; compositions and methods of using them
ECSP10010588A (es) Formulacion de medicamento solida con liberacion retardada
CL2007003130A1 (es) Uso de una formulacion de liberacion inmediata con un ingrediente activo seleccionado de pramipexol, hidrocloruro de pramipexol, dihidrocloruro de pramipexol monohidrato o una sal farmaceuticamente aceptable de este, para el tratamiento de la enferme
CL2011001829A1 (es) 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo.
MX2019009224A (es) Diacilhidrazina cristalina y sus usos.
AR075097A1 (es) Sales y formas polimorficas cristalinas de [4-(6-fluoro-7-metilamino-2,4-dioxo-1,4-dihidro-2h-quinazolin-3-il)-fenil]-5-cloro-tiofen-2-il-sulfonil urea, composiciones farmaceuticas que las contiene, metodo para prepararlas y uso de las mismas en el tratamiento de enfermedades cardiovasculares asocia
ECSP10010578A (es) Composicion farmaceutica 271
ES2581331T3 (es) Inhibidor de la progresión de una enfermedad atribuida a una acumulación anormal de grasa hepática
ECSP088088A (es) Maleato de 3-[2-(dimetilamino)metil-(ciclohex-1-il)]fenol y sus formas cristalinas
ECSP077263A (enExample)
CO7071134A2 (es) Formas cristalinas de cloruro de hidrógeno de 1-(3-terc-butil-1-p-tolil-1h-pirazol-5-il)-3-(5-fluoro-2-(1-(2-hidroxietil)-1h-indazol-5-iloxi)bencil)urea
PE20211391A1 (es) Procedimiento para la preparacion de (3s)-3-(4-cloro-3-{[(2s,3r)-2-(4-clorofenil)-4,4,4-trifluor-3-metilbutanoil]amino}fenil)-3-acido ciclopropilpropanoico y su forma cristalina para uso como principio activo farmaceutico